The total U.S. therapeutic neuromodulator market opportunity for Daxxify is $2.5 billion, including $345 million in cervical dystonia specifically, Revance said. (Ismail Rajo/Getty Images) After ...
The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...
It has been a little over three months since my last Botox injection.The symptom where my shoulder drops when I move my right ...
Dystonias are potentially disabling neurological conditions that can greatly affect quality of life. Effective treatments are sparse, with botulinum toxin (Botox) injections into the affected muscles ...
NEWPORT BEACH, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical company focused on the development of therapeutic indications for its ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC) a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that it has submitted a ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that Shanghai Fosun ...
You might know botulinum toxin as Botox: one of many brand names for the injectable drug that smooths wrinkles and facial creases. What you might not know is that botulinum toxin can also be used to ...
An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy. DystoniaBoTXNet could be a tool to aid ...
Dystonias are potentially disabling neurological conditions that can greatly affect quality of life. Effective treatments are sparse, with botulinum toxin (Botox) injections into the affected muscles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results